Michael Wolf
ORCID: 0000-0003-0259-9945
· 1 paper in corpus
nonrandomized-trial
2005
OBJECTIVE: To establish the use of aromatase inhibitors as a therapeutic option for endometriosis. DESIGN: Prospective open-label Food and Drug Administration phase 2 trial with Institutional Review Board approval. SETTING: Outpatient ter…